Literature DB >> 18082164

Complications of loop ileostomy and ileostomy closure and their implications for extended enterostomal therapy: a prospective clinical study.

M M G Rathnayake1, S K Kumarage, S R E Wijesuriya, B N L Munasinghe, M H J Ariyaratne, K I Deen.   

Abstract

INTRODUCTION: Patients who have a temporary loop ileostomy have impaired quality of life. Complications associated with a loop ileostomy or ileostomy closure will impair patients' quality of life further and require extended enterostomal therapy. We performed a prospective audit of loop ileostomy to ascertain the nature of the workload that may be created with ileostomy-related complications. PATIENTS AND METHODS: One hundred and forty patients (67 males, 73 females, median age 50 years, range 5-90 years) who received a temporary loop ileostomy were analysed after completion of proformas on a prospective basis between 1999 and 2006.
RESULTS: Operation was performed for rectal cancer 100 (71%), familial adenomatous polyposis 14 (10%), ulcerative colitis 21 (15%) and for trauma or Hirchsprung's disease 5 (3%). Complications of loop ileostomy were: retraction 1 (0.7%), ileostomy flux 11 (8%), stomal prolapse 1 (0.7%), parastomal hernia 1 (0.7%), paraileostomy abscess 4 (3%) and severe skin excoriation 9 (6%). The loop ileostomy was reversed in 117 (83%) at a median (range) of 13 weeks (1-60). Ileostomy closure-related complications were: small bowel fistula 1 (0.9%), small bowel obstruction 5 (4.3%) and a stitch sinus in 1 (0.9%). Five women developed recto-vaginal fistula (n=3; 2.6%), pouch-vaginal fistula (n=1; 0.9%) and pouch-anal fistula (n=1; 0.9%) that required extended enterostomal therapy, after loop ileostomy reversal.
CONCLUSION: Nineteen percent of patients following creation of a loop ileostomy and 10.5% of patients after reversal of the ileostomy required extended enterostomal care by a specialized enterostomal therapist, which supported resumption of a normal life.

Entities:  

Mesh:

Year:  2007        PMID: 18082164     DOI: 10.1016/j.ijnurstu.2007.07.015

Source DB:  PubMed          Journal:  Int J Nurs Stud        ISSN: 0020-7489            Impact factor:   5.837


  6 in total

Review 1.  The morbidity surrounding reversal of defunctioning ileostomies: a systematic review of 48 studies including 6,107 cases.

Authors:  Andre Chow; Henry S Tilney; Paraskevas Paraskeva; Santhini Jeyarajah; Emmanouil Zacharakis; Sanjay Purkayastha
Journal:  Int J Colorectal Dis       Date:  2009-02-17       Impact factor: 2.571

2.  A Snapshot of the International Views of the Treatment of Rectal Cancer Patients, a Multi-regional Survey: International Tendencies in Rectal Cancer.

Authors:  Antonio Caycedo-Marulanda; Sunil V Patel; Chris P Verschoor; Johanna P Uscategui; Sami A Chadi; Gabriela Moeslein; Manish Chand; Yasuko Maeda; John R T Monson; Steven D Wexner; Julio Mayol
Journal:  World J Surg       Date:  2020-10-08       Impact factor: 3.352

3.  Protection of low rectal anastomosis with a new tube ileostomy using a biofragmentable anastomosis ring: A retrospective study.

Authors:  Liming Liu; Qi Huang; Jialiang Wang; Quanning Chen; Rui Lin; Bujun Ge
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

4.  Factors affecting the morbidity and mortality of diverting stoma closure: retrospective cohort analysis of twelve-year period.

Authors:  Bojan Krebs; Arpad Ivanecz; Stojan Potrc; Matjaz Horvat
Journal:  Radiol Oncol       Date:  2019-09-24       Impact factor: 2.991

5.  Diverting ileostomy itself may not increase the rate of postoperative readmission related to dehydration after low anterior resection.

Authors:  Sung Sil Park; Min Jung Kim; Dong-Eun Lee; Sung Chan Park; Kyung Su Han; Chang Won Hong; Dae Kyung Sohn; Hee Jin Chang; Jae Hwan Oh
Journal:  Ann Surg Treat Res       Date:  2021-07-29       Impact factor: 1.859

6.  Early versus conventional stoma closure following bowel surgery: A randomized controlled trial.

Authors:  Thirugnanasambandam Nelson; Amuda R Pranavi; Sathasivam Sureshkumar; Gubbi S Sreenath; Vikram Kate
Journal:  Saudi J Gastroenterol       Date:  2018 Jan-Feb       Impact factor: 2.485

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.